Bibliografía y referencias

 

  • Emami Naini, A., Moradi, M., Mortazavi, M., Amini Harandi, A., Hadizadeh, M., Shirani, F., … Emami Naini, P. (2012). Effects of Oral L-Carnitine Supplementation on Lipid Profile, Anemia, and Quality of Life in Chronic Renal Disease Patients under Hemodialysis: A Randomized, Double-Blinded, Placebo-Controlled Trial. Journal of Nutrition and Metabolism, 2012. https://doi. org/10.1155/2012/510483
  • Fan, E., Zhang, L., Jiang, S., & Bai, Y. (2008). Beneficial Effects of Resveratrol on Atherosclerosis. Journal of Medicinal Food, 11(4), 610–614. https://doi.org/10.1089/jmf.2007.0091
  • Fuentes, M. C., Lajo, T., Carrión, J. M., & Cuñé, J. (2013). Cholesterol-lowering efficacy of Lactobacillus plantarum CECT 7527, 7528 and 7529 in hypercholesterolaemic adults. British Journal of Nutrition, 109(10), 1866–1872. https://doi.org/10.1017/S000711451200373X
  • Fundación Española del Corazón. (n.d.). Retrieved December 2, 2018, from https://fundaciondelcorazon.com/prevencion/riesgo-cardiovascular/colesterol.html
  • Gómez-Campos, R. (2009). La carnitina como suplemento nutricional. Educación Física – Chile, LXXX(No 268), 23–32.
  • Grau, M., a, Elosua, R., Le&#x000F3, C. de, N, A., Guembe, M., … Marrugat, J. (2011). Factores de riesgo cardiovascular en España en la primera década del siglo XXI : análisis agrupado con datos individuales de 11 estudios de base poblacional, estudio DARIOS. Revista Española de Cardiología, 64(04), 295–304. https://doi.org/10.1016/j.recesp.2010.11.005
  • Hernández, A. G., Perdomo, L., Escribano, Ó., & Benito, M. (2014). Papel del tejido adiposo blanco, marrón y perivascular en las complicaciones vasculares asociadas a la obesidad. Anales de La Real Academia Nacional de Farmacia, 80(2). Retrieved from http://www.analesranf.com/index.php/aranf/article/view/1474
  • Hobbs, T., Caso, R., McMahon, D., & Nymark, M. (2014). A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study. Alternative Therapies in Health and Medicine, 20(5), 18–23.
  • Hodges, R. E., & Minich, D. M. (2015). Modulation of Metabolic Detoxification Pathways Using Foods and Food-Derived Components: A Scientific Review with Clinical Application. Journal of Nutrition and Metabolism, 2015. https://doi.org/10.1155/2015/760689
  • Hormigo-Pozo, A., Mancera-Romero, J., Perez-Unanua, M. P., Alonso-Fernandez, M., Lopez-Simarro, F., & Mediavilla-Bravo, J. J. (2015). Recomendaciones de buena práctica en el tratamiento de la dislipemia en la diabetes. Medicina de Familia. SEMERGEN, 41(2), 89–98. https://doi.org/10.1016/j.semerg.2014.11.007
  • IMC | Instituto del Metabolismo Celular. (n.d.). Retrieved December 2, 2018, from http://www.metabolismo.biz/web/3-transporte-del-colesterol/
  • Jamilian, M., Amirani, E., & Asemi, Z. (2018). The effects of vitamin D and probiotic co-supplementation on glucose homeostasis, inflammation, oxidative stress and pregnancy outcomes in gestational diabetes: A randomized, double-blind, placebo-controlled trial. Clinical Nutrition. https://doi.org/10.1016/j.clnu.2018.10.028
  • Karl, M., Rubenstein, M., Rudnick, C., & Brejda, J. (2012). A multicenter study of nutraceutical drinks for cholesterol (evaluating effectiveness and tolerability). Journal of Clinical Lipidology, 6(2), 150–158. https://doi.org/10.1016/j.jacl.2011.09.004
  • Klop, B., Elte, J. W. F., & Castro Cabezas, M. (2013). Dyslipidemia in Obesity: Mechanisms and Potential Targets. Nutrients, 5(4), 1218–1240. https://doi.org/10.3390/nu5041218
  • Lee, J. M. S., Robson, M. D., Yu, L.-M., Shirodaria, C. C., Cunnington, C., Kylintireas, I., … Choudhury, R. P. (2009). Effects of High-Dose Modified-Release Nicotinic Acid on Atherosclerosis and Vascular Function: A Randomized, Placebo-Controlled, Magnetic Resonance Imaging Study. Journal of the American College of Cardiology, 54(19), 1787–1794. https://doi.org/10.1016/j. jacc.2009.06.036
  • León-Pedroza, J. I., González-Tapia, L. A., del Olmo-Gil, E., Castellanos-Rodríguez, D., Escobedo, G., & González-Chávez, A. (2015). Inflamación sistémica de grado bajo y su relación con el desarrollo de enfermedades metabólicas: de la evidencia molecular a la aplicación clínica. Cirugía y Cirujanos, 83(6), 543–551. https://doi.org/10.1016/j.circir.2015.05.041
  • Libby, P. (2016). Patogenia, prevención y tratamiento de la aterosclerosis. In D. Kasper, A. Fauci, S. Hauser, D. Longo, J. L. Jameson, & J. Loscalzo (Eds.), Harrison. Principios de Medicina Interna, 19e (Vols. 1–Book, Section). New York, NY: McGraw-Hill Education. Retrieved from harrisonmedicina.mhmedical.com/content.aspx?aid=1137934894
  • Linus Pauling Institute. (2014, May 19). Retrieved November 11, 2018, from https://lpi.oregonstate.edu/es/mic/vitaminas/niacina
  • Lípidos: concepto y clasificación. (n.d.). Retrieved November 21, 2018, from https://www.infobiologia.net/2011/08/lipidos-concepto-y-clasificacion.html
  • Ma, J., Zhou, Q., & Li, H. (2017). Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy. Nutrients, 9(10). https://doi.org/10.3390/nu9101124
  • Mahbub, M., Yamaguchi, N., Takahashi, H., Hase, R., Ishimaru, Y., Sunagawa, H., … Tanabe, T. (2017). Association of plasma free amino acids with hyperuricemia in relation to diabetes mellitus, dyslipidemia, hypertension and metabolic syndrome. Scientific Reports, 7. https://doi.org/10.1038/s41598-017-17710-6
  • Maldonado Saavedra, O., Ramírez Sánchez, I., García Sánchez, J. R., Ceballos Reyes, G. M., & Méndez Bolaina, E. (2012). Colesterol: Función biológica e implicaciones médicas. Revista Mexicana de Ciencias Farmacéuticas, 43(2), 7–22.
  • Manual MSD. (n.d.). Retrieved November 16, 2018, from https://www.msdmanuals.com/es/professional/trastornos-endocrinos-y-metab%C3%B3licos/trastornos-de-los-l%C3%ADpidos/ dislipidemia
  • MárquezVillalobos, F. ., & Ramírez-Emiliano, J. (2017). Uso de Probióticos para el Control de la Hipercolesterolemia. ARCHIVOS DE MEDICINA, 13(4), 5.
  • McCarty, M. F. (2000). Co-administration of equimolar doses of betaine may alleviate the hepatotoxic risk associated with niacin therapy. Medical Hypotheses, 55(3), 189–194. https://doi. org/10.1054/mehy.1999.1011
  • Meydani, M. (2001). Vitamin E and atherosclerosis: beyond prevention of LDL oxidation. The Journal of Nutrition, 131(2), 366S-8S. https://doi.org/10.1093/jn/131.2.366S
  • Milman, U., Blum, S., Shapira, C., Aronson, D., Miller-Lotan, R., Anbinder, Y., … Levy, A. P. (2008). Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial. Arteriosclerosis, Thrombosis, and Vascular Biology, 28(2), 341–347. https://doi.org/10.1161/ATVBAHA.107.153965
  • Ooi, L.-G., & Liong, M.-T. (2010). Cholesterol-Lowering Effects of Probiotics and Prebiotics: A Review of in Vivo and in Vitro Findings. International Journal of Molecular Sciences, 11(6), 2499–2522. https://doi.org/10.3390/ijms11062499
  • Panahi, Y., Ahmadi, Y., Teymouri, M., Johnston, T. P., & Sahebkar, A. (2018). Curcumin as a potential candidate for treating hyperlipidemia: A review of cellular and metabolic mechanisms. Journal of Cellular Physiology, 233(1), 141–152. https://doi.org/10.1002/jcp.25756
  • Panico, A., Lupoli, G. A., Lupoli, R., Romano, F., Barba, L., & Lupoli, G. (2017). Resveratrol improves the lipid profile promoted by red yeast rice (monacolin k) in patients with moderate dyslipidemia: An open-label, randomized, parallel-group controlled clinical trial. The EuroBiotech Journal, 1(1), 72–75. https://doi.org/10.24190/ISSN2564-615X/2017/01.11
  • Patti, A. M., Al-Rasadi, K., Katsiki, N., Banerjee, Y., Nikolic, D., Vanella, L., … Rizzo, M. (2015). Effect of a Natural Supplement Containing Curcuma Longa, Guggul, and Chlorogenic Acid in Patients With Metabolic Syndrome. Angiology, 66(9), 856–861. https://doi.org/10.1177/0003319714568792
  • Peterson, C. T., Sharma, V., Uchitel, S., Denniston, K., Chopra, D., Mills, P. J., & Peterson, S. N. (2018). Prebiotic Potential of Herbal Medicines Used in Digestive Health and Disease. Journal of Alternative and Complementary Medicine, 24(7), 656–665. https://doi.org/10.1089/acm.2017.0422
  • Qin, S., Huang, L., Gong, J., Shen, S., Huang, J., Ren, H., & Hu, H. (2017). Efficacy and safety of turmeric and curcumin in lowering blood lipid levels in patients with cardiovascular risk factors: a meta-analysis of randomized controlled trials. Nutrition Journal, 16(1), 68. https://doi.org/10.1186/s12937-017-0293-y
  • Ramanathan, N., Tan, E., Loh, L. J., Soh, B. S., & Yap, W. N. (2018). Tocotrienol is a cardioprotective agent against ageing-associated cardiovascular disease and its associated morbidities. Nutrition & Metabolism, 15. https://doi.org/10.1186/s12986-018-0244-4
  • Rerksuppaphol, S., & Rerksuppaphol, L. (2015). A Randomized Double-blind Controlled Trial of Lactobacillus acidophilus Plus Bifidobacterium bifidum versus Placebo in Patients with Hypercholesterolemia. Journal of Clinical and Diagnostic Research : JCDR, 9(3), KC01–KC04. https://doi.org/10.7860/JCDR/2015/11867.5728
  • Roberfroid, M., Gibson, G. R., Hoyles, L., McCartney, A. L., Rastall, R., Rowland, I., … Meheust, A. (2010). Prebiotic effects: metabolic and health benefits. British Journal of Nutrition, 104(S2), S1–S63. https://doi.org/10.1017/S0007114510003363
  • Roozbeh, J., Shahriyari, B., Akmali, M., Vessal, G., Pakfetrat, M., Jalali, G. A. R., … Ghahramani, N. (2011). Comparative Effects of Silymarin and Vitamin E Supplementation on Oxidative Stress Markers, and Hemoglobin Levels among Patients on Hemodialysis. Renal Failure, 33(2), 118–123. https://doi.org/10.3109/0886022X.2010.541579
  • Sahebkar, A., Saboni, N., Pirro, M., & Banach, M. (2017). Curcumin: An effective adjunct in patients with statin‐associated muscle symptoms? Journal of Cachexia, Sarcopenia and Muscle, 8(1), 19–24. https://doi.org/10.1002/jcsm.12140
  • Sanchez, M., Darimont, C., Drapeau, V., Emady-Azar, S., Lepage, M., Rezzonico, E., … Tremblay, A. (2014). Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and women. British Journal of Nutrition, 111(8), 1507–1519. https://doi.org/10.1017/S0007114513003875
  • Sanchez, M., Panahi, S., & Tremblay, A. (2014). Childhood Obesity: A Role for Gut Microbiota? International Journal of Environmental Research and Public Health, 12(1), 162–175. https://doi. org/10.3390/ijerph120100162
  • Sánchez, R., Pérez, M., Lefler, J., Rubio, J., Rubio, M., & Fuster, R. (2001). Hiperlipoproteinemias. Abordaje terapéutico. Farmacia Profesional, 15(6), 48–61.
  • Seyed Mohammad Mousavi, Alireza Milajerdi, Hamed Kord Varkaneh,Mohammad Mohsen Gorjipour & Ahmad Esmaillzadeh (2018): The effects of curcumin supplementation on body weight, body mass index and waist circumference: a systematic review and dose-response meta-analysis of randomized controlled trials, Critical Reviews in Food Science and Nutrition, DOI: 10.1080/10408398.2018.1517724
  • Shepherd, J., Betteridge, J., Van Gaal, L., & European Consensus Panel. (2005). Nicotinic acid in the management of dyslipidaemia associated with diabetes and metabolic syndrome: a position paper developed by a European Consensus Panel. Current Medical Research and Opinion, 21(5), 665–682. https://doi.org/10.1185/030079905X43677
  • Shimizu, M., Hashiguchi, M., Shiga, T., Tamura, H., & Mochizuki, M. (2015). Meta-Analysis: Effects of Probiotic Supplementation on Lipid Profiles in Normal to Mildly Hypercholesterolemic Individuals. PLOS ONE, 10(10), e0139795. https://doi.org/10.1371/journal.pone.0139795
  • Simental-Mendía, L. E., & Guerrero-Romero, F. (2019). Effect of resveratrol supplementation on lipid profile in subjects with dyslipidemia: A randomized double-blind, placebo-controlled trial. Nutrition, 58, 7–10. https://doi.org/10.1016/j.nut.2018.06.015
  • Soca, P. M. . (2009). Dislipidemias. ACIMED, 20(6), 265–273.
  • Sorrentino, S. A., Besler, C., Rohrer, L., Meyer, M., Heinrich, K., Bahlmann, F. H., … Landmesser, U. (2010). Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy. Circulation, 121(1), 110–122. https://doi.org/10.1161/CIRCULATIONAHA.108.83634
  • Sugino, T., Shirai, T., Kajimoto, Y., & Kajimoto, O. (2008). l-Ornithine supplementation attenuates physical fatigue in healthy volunteers by modulating lipid and amino acid metabolism. Nutrition Research, 28(11), 738–743. https://doi.org/10.1016/j.nutres.2008.08.008
  • Timmers, S., Konings, E., Bilet, L., Houtkooper, R. H., van de Weijer, T., Goossens, G. H., … Schrauwen, P. (2011). Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans. Cell Metabolism, 14(5), 612–622. https://doi.org/10.1016/j.cmet.2011.10.002
  • WebMD. (n.d.). Retrieved November 19, 2018, from https://www.webmd.com/vitamins/index
  • WHO- Obesity and overweight. (n.d.). Retrieved November 16, 2018, from http://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
  • Xiao, J., So, K. F., Liong, E. C., & Tipoe, G. L. (2013). Recent Advances in the Herbal Treatment of Non-Alcoholic Fatty Liver Disease. Journal of Traditional and Complementary Medicine, 3(2), 88–94. https://doi.org/10.4103/2225-4110.110411
  • Yi-Sun Yang, Ying-Fang Su, Hui-Wen Yang, Yu-Hsien Lee, Janet I. Chou and Kwo-Chang Ueng. Lipid-Lowering Effects of Curcumin in Patients with Metabolic Syndrome: A Randomized, Double- Blind, Placebo-Controlled Trial. Phytother. Res. (2014). Published online in Wiley Online Library (wileyonlinelibrary.com) DOI: 10.1002/ptr.519
  • Yunes Panahi, Yasin Ahmadi, Manouchehr Teymouri, Thomas P. Johnston, Amirhossein Sahebkare (2016). Curcumin as a potential candidate for treating hyperlipidemia: A review of cellular and metabolic mechanisms. Accepted 21 December 2016 Journal of Cellular Physiology. DOI: [10.1002/jcp.25756]